Gambaran Umum
Swedish Orphan Biovitrum AB (publ), commonly known as Sobi, is a biopharmaceutical company based in Stockholm, Sweden. Specializing in the development and commercialization of innovative treatments in rare diseases, Sobi's primary focus areas include immunology and hematology. Key projects and products in its portfolio address conditions such as hemophilia, genetic metabolic disorders, and inflammatory diseases. In pursuit of expanding its therapeutic impact, Sobi actively engages in both in-house development and collaborations with external partners to enhance its pipeline and reach. The company's strategic approach pivots on advancing science to meet unfulfilled therapeutic needs, aiming particularly to improve the lives of those afflicted by rare disease conditions around the globe.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Swedish Orphan Biovitrum AB (publ) per 2025 Jun 30 adalah 26,970.00 MM.
- Nilai operating income untuk Swedish Orphan Biovitrum AB (publ) per 2025 Jun 30 adalah 6,410.00 MM.
- Nilai net income untuk Swedish Orphan Biovitrum AB (publ) per 2025 Jun 30 adalah 4,372.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 26,970.00 | 6,410.00 | 4,372.00 |
| 2025-03-31 | 26,236.00 | 5,804.00 | 3,960.00 |
| 2024-12-31 | 26,027.00 | 5,823.00 | 3,885.00 |
| 2024-09-30 | 25,435.00 | 6,060.00 | 3,514.00 |
| 2024-06-30 | 23,710.00 | 4,616.00 | 2,145.00 |
| 2024-03-31 | 23,140.00 | 4,627.00 | 2,142.00 |
| 2023-12-31 | 22,123.00 | 4,653.00 | 2,409.00 |
| 2023-09-30 | 21,270.00 | 4,741.00 | 2,769.00 |
| 2023-06-30 | 20,100.00 | 4,792.00 | 3,125.00 |
| 2023-03-31 | 19,104.00 | 4,577.00 | 3,162.00 |
| 2022-12-31 | 18,790.00 | 4,520.00 | 2,638.00 |
| 2022-09-30 | 17,696.00 | 4,159.00 | 2,493.00 |
| 2022-06-30 | 17,458.00 | 4,167.00 | 2,516.00 |
| 2022-03-31 | 16,793.00 | 4,198.00 | 2,526.00 |
| 2021-12-31 | 15,529.00 | 3,794.00 | 2,679.00 |
| 2021-09-30 | 15,214.00 | 3,968.00 | 2,940.00 |
| 2021-06-30 | 14,424.00 | 3,724.00 | 2,744.00 |
| 2021-03-31 | 14,283.00 | 3,799.00 | 2,759.00 |
| 2020-12-31 | 15,261.00 | 4,463.00 | 3,245.00 |
| 2020-09-30 | 15,570.00 | 4,741.00 | 3,103.00 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | 11.56 | 11.43 |
| 2024-12-31 | 11.37 | 11.24 |
| 2024-09-30 | 10.21 | 10.08 |
| 2024-06-30 | ||
| 2024-03-31 | 6.42 | 6.36 |
| 2023-12-31 | 7.47 | 7.39 |
| 2023-09-30 | 8.98 | 8.90 |
| 2023-06-30 | 10.55 | 10.44 |
| 2023-03-31 | 10.69 | 10.57 |
| 2022-12-31 | 8.92 | 8.84 |
| 2022-09-30 | 8.44 | 8.37 |
| 2022-06-30 | 8.52 | 8.45 |
| 2022-03-31 | 8.56 | 8.53 |
| 2021-12-31 | 9.08 | 9.03 |
| 2021-09-30 | 9.97 | 9.89 |
| 2021-06-30 | 9.30 | 9.23 |
| 2021-03-31 | 9.36 | 9.25 |
| 2020-12-31 | 11.01 | 10.90 |
| 2020-09-30 | 10.54 | 10.45 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Swedish Orphan Biovitrum AB (publ) per 2025 Jun 30 adalah 6,545.00 MM.
- Nilai cash from investing activities untuk Swedish Orphan Biovitrum AB (publ) per 2025 Jun 30 adalah -2,822.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Swedish Orphan Biovitrum AB (publ) per 2025 Jun 30 adalah -3,375.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 6,545.00 | -2,822.00 | -3,375.00 |
| 2025-03-31 | 7,427.00 | -2,440.00 | -4,429.00 |
| 2024-12-31 | 7,388.00 | -3,091.00 | -4,001.00 |
| 2024-09-30 | 6,663.00 | -3,448.00 | -3,209.00 |
| 2024-06-30 | 6,716.00 | -1,659.00 | -5,039.00 |
| 2024-03-31 | 4,743.00 | -19,391.00 | 14,985.00 |
| 2023-12-31 | 4,470.00 | -21,904.00 | 17,012.00 |
| 2023-09-30 | 5,291.00 | -21,509.00 | 16,599.00 |
| 2023-06-30 | 5,066.00 | -21,819.00 | 17,146.00 |
| 2023-03-31 | 4,915.00 | -4,578.00 | -1,249.00 |
| 2022-12-31 | 4,576.00 | -1,477.00 | -2,902.00 |
| 2022-09-30 | 4,804.00 | -1,659.00 | -3,178.00 |
| 2022-06-30 | 4,317.00 | -953.00 | -3,304.00 |
| 2022-03-31 | 5,415.00 | -433.00 | -4,581.00 |
| 2021-12-31 | 5,470.00 | -367.00 | -4,474.00 |
| 2021-09-30 | 4,066.00 | -2,650.00 | -1,361.00 |
| 2021-06-30 | 4,190.00 | -3,922.00 | -232.00 |
| 2021-03-31 | 4,739.00 | -4,031.00 | -893.00 |
| 2020-12-31 | 4,926.00 | -3,964.00 | -1,282.00 |
| 2020-09-30 | 5,185.00 | -10,173.00 | 4,080.00 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | |||
| 2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 | ||
| 2020-09-30 |
Efektivitas Manajemen
- roa untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.05.
- roe untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.12.
- roic untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.07.
- croic untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.01.
- ocroic untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.13.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | 0.05 | 0.12 | 0.07 | 0.01 | 0.13 |
| 2025-03-31 | 0.05 | 0.11 | 0.07 | 0.00 | 0.13 |
| 2024-12-31 | 0.05 | 0.10 | 0.06 | -0.00 | 0.12 |
| 2024-09-30 | 0.05 | 0.10 | 0.06 | -0.00 | 0.12 |
| 2024-06-30 | 0.04 | 0.08 | 0.04 | 0.01 | 0.08 |
| 2024-03-31 | 0.05 | 0.09 | 0.04 | -0.01 | 0.08 |
| 2023-12-31 | 0.05 | 0.11 | 0.05 | 0.01 | 0.10 |
| 2023-09-30 | 0.06 | 0.13 | 0.06 | 0.01 | 0.09 |
| 2023-06-30 | 0.06 | 0.13 | 0.05 | 0.01 | 0.09 |
| 2023-03-31 | 0.06 | 0.13 | 0.08 | -0.02 | 0.13 |
| 2022-12-31 | 0.05 | 0.11 | 0.07 | 0.00 | 0.14 |
| 2022-09-30 | 0.05 | 0.11 | 0.07 | 0.00 | 0.14 |
| 2022-06-30 | 0.05 | 0.12 | 0.07 | 0.00 | 0.13 |
| 2022-03-31 | 0.05 | 0.12 | 0.08 | 0.01 | 0.16 |
| 2021-12-31 | 0.06 | 0.13 | 0.08 | 0.02 | 0.16 |
| 2021-09-30 | 0.07 | 0.16 | 0.09 | 0.00 | 0.13 |
| 2021-06-30 | 0.06 | 0.15 | 0.08 | 0.00 | 0.14 |
| 2021-03-31 | 0.06 | 0.15 | 0.08 | -0.01 | 0.15 |
| 2020-12-31 | 0.07 | 0.19 | 0.09 | -0.01 | 0.14 |
| 2020-09-30 | 0.09 | 0.20 | 0.10 | -0.03 | 0.16 |
Gross Margins
- marjin kotor untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.78.
- marjin bersih untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.15.
- marjin operasi untuk Swedish Orphan Biovitrum AB (publ) pada 2025 Jun 30 adalah 0.22.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | 0.78 | 0.15 | 0.22 |
| 2025-03-31 | 0.78 | 0.15 | 0.22 |
| 2024-12-31 | 0.79 | 0.14 | 0.24 |
| 2024-09-30 | 0.79 | 0.14 | 0.24 |
| 2024-06-30 | 0.77 | 0.09 | 0.20 |
| 2024-03-31 | 0.78 | 0.11 | 0.20 |
| 2023-12-31 | 0.77 | 0.13 | 0.22 |
| 2023-09-30 | 0.77 | 0.16 | 0.24 |
| 2023-06-30 | 0.77 | 0.16 | 0.24 |
| 2023-03-31 | 0.77 | 0.17 | 0.24 |
| 2022-12-31 | 0.77 | 0.14 | 0.24 |
| 2022-09-30 | 0.77 | 0.14 | 0.24 |
| 2022-06-30 | 0.76 | 0.14 | 0.24 |
| 2022-03-31 | 0.77 | 0.15 | 0.25 |
| 2021-12-31 | 0.78 | 0.17 | 0.24 |
| 2021-09-30 | 0.78 | 0.19 | 0.26 |
| 2021-06-30 | 0.79 | 0.19 | 0.26 |
| 2021-03-31 | 0.80 | 0.19 | 0.27 |
| 2020-12-31 | 0.79 | 0.21 | 0.29 |
| 2020-09-30 | 0.78 | 0.20 | 0.30 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 1789731 |
